{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T06:57:57Z","timestamp":1790146677797,"version":"4.0.1"},"publisher-location":"Cham","reference-count":100,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030332488","type":"print"},{"value":"9783030332495","type":"electronic"}],"license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019]]},"DOI":"10.1007\/5584_2019_402","type":"book-chapter","created":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T13:07:33Z","timestamp":1563973653000},"page":"19-33","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Molecular Epidemiology of Bordetella pertussis"],"prefix":"10.1007","author":[{"given":"Alex-Mikael","family":"Barkoff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiushui","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,25]]},"reference":[{"issue":"7","key":"402_CR1","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.1128\/JCM.42.7.2890-2897.2004","volume":"42","author":"A Advani","year":"2004","unstructured":"Advani A, Donnelly D, Hallander H (2004) Reference system for characterization of Bordetella pertussis pulsed-field gel electrophoresis profiles. J Clin Microbiol 42(7):2890\u20132897","journal-title":"J Clin Microbiol"},{"issue":"3","key":"402_CR2","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.mimet.2009.06.019","volume":"78","author":"A Advani","year":"2009","unstructured":"Advani A, Van der Heide HG, Hallander HO et al (2009) Analysis of Swedish Bordetella pertussis isolates with three typing methods: characterization of an epidemic lineage. J Microbiol Methods 78(3):297\u2013301","journal-title":"J Microbiol Methods"},{"issue":"2","key":"402_CR3","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1128\/JCM.02036-12","volume":"51","author":"A Advani","year":"2013","unstructured":"Advani A, Hallander HO, Dalby T et al (2013) Pulsed-field gel electrophoresis analysis of Bordetella pertussis isolates circulating in Europe from 1998 to 2009. J Clin Microbiol 51(2):422\u2013428","journal-title":"J Clin Microbiol"},{"issue":"11","key":"402_CR4","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1128\/CVI.00355-12","volume":"19","author":"F Alexander","year":"2012","unstructured":"Alexander F, Matheson M, Fry NK et al (2012) Antibody responses to individual Bordetella pertussis fimbrial antigen Fim2 or Fim3 following immunization with the five-component acellular pertussis vaccine or to pertussis disease. Clin Vaccine Immunol 19(11):1776\u20131783","journal-title":"Clin Vaccine Immunol"},{"key":"402_CR5","doi-asserted-by":"crossref","DOI":"10.1186\/s12879-016-1700-2","volume":"16","author":"H Bailon","year":"2016","unstructured":"Bailon H, Leon-Janampa N, Padilla C et al (2016) Increase in pertussis cases along with high prevalence of two emerging genotypes of Bordetella pertussis in Peru, 2012. BMC Infect Dis 16:422-016-1700-2","journal-title":"BMC Infect Dis"},{"issue":"10","key":"402_CR6","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1128\/CVI.00367-12","volume":"19","author":"AM Barkoff","year":"2012","unstructured":"Barkoff AM, Mertsola J, Guillot S et al (2012) Appearance of Bordetella pertussis strains not expressing the vaccine antigen pertactin in Finland. Clin Vaccine Immunol 19(10):1703\u20131704","journal-title":"Clin Vaccine Immunol"},{"key":"402_CR7","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jim.2014.06.001","volume":"408","author":"AM Barkoff","year":"2014","unstructured":"Barkoff AM, Guiso N, Guillot S et al (2014) A rapid ELISA-based method for screening Bordetella pertussis strain production of antigens included in current acellular pertussis vaccines. J Immunol Methods 408:142\u2013148","journal-title":"J Immunol Methods"},{"issue":"7","key":"402_CR8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/femspd\/ftv050","volume":"73","author":"AM Barkoff","year":"2015","unstructured":"Barkoff AM, Grondahl-Yli-Hannuksela K, He Q (2015) Seroprevalence studies of pertussis: what have we learned from different immunized populations. Pathog Dis 73(7):10","journal-title":"Pathog Dis"},{"key":"402_CR9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1128\/JCM.01998-17","volume":"56","author":"AM Barkoff","year":"2018","unstructured":"Barkoff AM, Mertsola J, Pierard D et al (2018) Surveillance of circulating Bordetella pertussis strains in Europe during 1998\u20132015. J Clin Microbiol 56:5","journal-title":"J Clin Microbiol"},{"issue":"7","key":"402_CR10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2807\/1560-7917.ES.2019.24.7.1700832","volume":"24","author":"AM Barkoff","year":"2019","unstructured":"Barkoff AM, Mertsola J, Pierard D et al (2019) Pertactin-deficient Bordetella pertussis isolates: evidence of increased circulation in Europe, 1998 to 2015. Euro Surveill 24(7):10","journal-title":"Euro Surveill"},{"issue":"2","key":"402_CR11","first-page":"e01074","volume":"5","author":"MJ Bart","year":"2014","unstructured":"Bart MJ, Harris SR, Advani A et al (2014) Global population structure and evolution of Bordetella pertussis and their relationship with vaccination. MBio 5(2):e01074\u2013e01014","journal-title":"MBio"},{"issue":"6","key":"402_CR12","first-page":"10","volume":"3","author":"MJ Bart","year":"2015","unstructured":"Bart MJ, van der Heide HG, Zeddeman A et al (2015) Complete Genome Sequences of 11 Bordetella pertussis Strains Representing the Pandemic ptxP3 Lineage. Genome Announc 3(6):10","journal-title":"Genome Announc"},{"issue":"3","key":"402_CR13","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1128\/JCM.41.3.1167-1172.2003","volume":"41","author":"JM Bartkus","year":"2003","unstructured":"Bartkus JM, Juni BA, Ehresmann K et al (2003) Identification of a mutation associated with erythromycin resistance in Bordetella pertussis: implications for surveillance of antimicrobial resistance. J Clin Microbiol 41(3):1167\u20131172","journal-title":"J Clin Microbiol"},{"issue":"43","key":"402_CR14","doi-asserted-by":"crossref","first-page":"6034","DOI":"10.1016\/j.vaccine.2009.07.074","volume":"27","author":"V Bouchez","year":"2009","unstructured":"Bouchez V, Brun D, Cantinelli T et al (2009) First report and detailed characterization of B. pertussis isolates not expressing Pertussis Toxin or Pertactin. Vaccine 27(43):6034\u20136041","journal-title":"Vaccine"},{"issue":"3","key":"402_CR15","doi-asserted-by":"crossref","first-page":"751","DOI":"10.3390\/vaccines3030751","volume":"3","author":"V Bouchez","year":"2015","unstructured":"Bouchez V, Hegerle N, Strati F et al (2015) New data on vaccine antigen deficient bordetella pertussis isolates. Vaccines (Basel) 3(3):751\u2013770","journal-title":"Vaccines (Basel)"},{"issue":"19","key":"402_CR16","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/MRA.01207-18","volume":"7","author":"V Bouchez","year":"2018","unstructured":"Bouchez V, Baines SL, Guillot S et al (2018) Complete genome sequences of bordetella pertussis clinical isolate FR5810 and reference strain tohama from combined Oxford nanopore and illumina sequencing. Microbiol Resour Announc 7(19):10","journal-title":"Microbiol Resour Announc"},{"issue":"10","key":"402_CR17","doi-asserted-by":"crossref","first-page":"3549","DOI":"10.1128\/JCM.01189-14","volume":"52","author":"KE Bowden","year":"2014","unstructured":"Bowden KE, Williams MM, Cassiday PK et al (2014) Molecular epidemiology of the pertussis epidemic in Washington State in 2012. J Clin Microbiol 52(10):3549\u20133557","journal-title":"J Clin Microbiol"},{"issue":"3","key":"402_CR18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/mSphere.00036-16","volume":"1","author":"KE Bowden","year":"2016","unstructured":"Bowden KE, Weigand MR, Peng Y et al (2016) Genome structural diversity among 31 bordetella pertussis Isolates from two recent U.S. Whooping cough statewide epidemics. mSphere 1(3):10","journal-title":"mSphere"},{"issue":"4","key":"402_CR19","volume":"7","author":"P Campbell","year":"2012","unstructured":"Campbell P, McIntyre P, Quinn H et al (2012) Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia. PLoS One 7(4):e35874","journal-title":"PLoS One"},{"issue":"6","key":"402_CR20","doi-asserted-by":"crossref","first-page":"987","DOI":"10.3201\/eid1206.051283","volume":"12","author":"V Caro","year":"2006","unstructured":"Caro V, Elomaa A, Brun D et al (2006) Bordetella pertussis, Finland and France. Emerg Infect Dis 12(6):987\u2013989","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"402_CR21","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1086\/315881","volume":"182","author":"P Cassiday","year":"2000","unstructured":"Cassiday P, Sanden G, Heuvelman K et al (2000) Polymorphism in Bordetella pertussis pertactin and pertussis toxin virulence factors in the United States, 1935\u20131999. J Infect Dis 182(5):1402\u20131408","journal-title":"J Infect Dis"},{"issue":"3","key":"402_CR22","doi-asserted-by":"crossref","first-page":"442","DOI":"10.3201\/eid2203.151136","volume":"22","author":"PK Cassiday","year":"2016","unstructured":"Cassiday PK, Skoff TH, Jawahir S et al (2016) Changes in predominance of pulsed-field gel electrophoresis profiles of bordetella pertussis isolates, United States, 2000\u20132012. Emerg Infect Dis 22(3):442\u2013448","journal-title":"Emerg Infect Dis"},{"issue":"44","key":"402_CR23","first-page":"807","volume":"43","author":"Centers for Disease Control and Prevention (CDC)","year":"1994","unstructured":"Centers for Disease Control and Prevention (CDC) (1994) Erythromycin-resistant Bordetella pertussis--Yuma County, Arizona, May-October 1994. MMWR Morb Mortal Wkly Rep 43(44):807\u2013810","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"402_CR24","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/j.1365-2958.2010.07293.x","volume":"77","author":"Q Chen","year":"2010","unstructured":"Chen Q, Decker KB, Boucher PE et al (2010) Novel architectural features of Bordetella pertussis fimbrial subunit promoters and their activation by the global virulence regulator BvgA. Mol Microbiol 77(5):1326\u20131340","journal-title":"Mol Microbiol"},{"issue":"3","key":"402_CR25","doi-asserted-by":"crossref","first-page":"S259","DOI":"10.1093\/infdis\/174.Supplement_3.S259","volume":"174","author":"JD Cherry","year":"1996","unstructured":"Cherry JD (1996) Historical review of pertussis and the classical vaccine. J Infect Dis 174(3):S259\u2013S263","journal-title":"J Infect Dis"},{"issue":"7","key":"402_CR26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003418","volume":"9","author":"JD Cherry","year":"2013","unstructured":"Cherry JD (2013) Pertussis: challenges today and for the future. PLoS Pathog 9(7):e1003418","journal-title":"PLoS Pathog"},{"issue":"7","key":"402_CR27","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s10096-016-2655-3","volume":"35","author":"Q Du","year":"2016","unstructured":"Du Q, Wang X, Liu Y et al (2016) Direct molecular typing of Bordetella pertussis from nasopharyngeal specimens in China in 2012\u20132013. Eur J Clin Microbiol Infect Dis 35(7):1211\u20131214","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"4","key":"402_CR28","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1128\/AEM.18.4.618-621.1969","volume":"18","author":"G Eldering","year":"1969","unstructured":"Eldering G, Holwerda J, Davis A et al (1969) Bordetella pertussis serotypes in the United States. Appl Microbiol 18(4):618\u2013621","journal-title":"Appl Microbiol"},{"issue":"8","key":"402_CR29","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1128\/JCM.43.8.3681-3687.2005","volume":"43","author":"A Elomaa","year":"2005","unstructured":"Elomaa A, Advani A, Donnelly D et al (2005) Strain variation among Bordetella pertussis isolates in finland, where the whole-cell pertussis vaccine has been used for 50 years. J Clin Microbiol 43(8):3681\u20133687","journal-title":"J Clin Microbiol"},{"key":"402_CR30","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/INF.0000000000002160","volume":"38","author":"P Fu","year":"2018","unstructured":"Fu P, Wang C, Tian H et al (2018) Bordetella pertussis Infection in Infants and Young Children in Shanghai, China, 2016\u20132017: clinical features, genotype variations of antigenic genes and macrolides resistance. Pediatr Infect Dis J 38:370\u2013376. \nhttps:\/\/doi.org\/10.1097\/INF.0000000000002160","journal-title":"Pediatr Infect Dis J"},{"key":"402_CR31","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.ijid.2015.04.001","volume":"35","author":"SR Galit","year":"2015","unstructured":"Galit SR, Otsuka N, Furuse Y et al (2015) Molecular epidemiology of Bordetella pertussis in the Philippines in 2012\u20132014. Int J Infect Dis 35:24\u201326","journal-title":"Int J Infect Dis"},{"issue":"10","key":"402_CR32","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1586\/14760584.2014.930667","volume":"13","author":"AR Gorringe","year":"2014","unstructured":"Gorringe AR, Vaughan TE (2014) Bordetella pertussis fimbriae (Fim): relevance for vaccines. Expert Rev Vaccines 13(10):1205\u20131214","journal-title":"Expert Rev Vaccines"},{"issue":"6","key":"402_CR33","doi-asserted-by":"crossref","first-page":"966","DOI":"10.3201\/eid1806.120091","volume":"18","author":"S Guillot","year":"2012","unstructured":"Guillot S, Descours G, Gillet Y et al (2012) Macrolide-resistant Bordetella pertussis infection in newborn girl, France. Emerg Infect Dis 18(6):966\u2013968","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"402_CR34","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1128\/JCM.43.6.2856-2865.2005","volume":"43","author":"HO Hallander","year":"2005","unstructured":"Hallander HO, Advani A, Donnelly D et al (2005) Shifts of Bordetella pertussis variants in Sweden from 1970 to 2003, during three periods marked by different vaccination programs. J Clin Microbiol 43(6):2856\u20132865","journal-title":"J Clin Microbiol"},{"issue":"9","key":"402_CR35","doi-asserted-by":"crossref","first-page":"E340","DOI":"10.1111\/j.1469-0691.2012.03925.x","volume":"18","author":"N Hegerle","year":"2012","unstructured":"Hegerle N, Paris AS, Brun D et al (2012) Evolution of French Bordetella pertussis and Bordetella parapertussis isolates: increase of Bordetellae not expressing pertactin. Clin Microbiol Infect 18(9):E340\u2013E346","journal-title":"Clin Microbiol Infect"},{"key":"402_CR36","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2180-8-162","volume":"8","author":"E Heikkinen","year":"2008","unstructured":"Heikkinen E, Xing DK, Olander RM et al (2008) Bordetella pertussis isolates in Finland: serotype and fimbrial expression. BMC Microbiol 8:162-2180-8-162","journal-title":"BMC Microbiol"},{"issue":"4","key":"402_CR37","doi-asserted-by":"crossref","first-page":"699","DOI":"10.3201\/eid2304.161575","volume":"23","author":"Y Hiramatsu","year":"2017","unstructured":"Hiramatsu Y, Miyaji Y, Otsuka N et al (2017) Significant decrease in pertactin-deficient bordetella pertussis Isolates, Japan. Emerg Infect Dis 23(4):699\u2013701","journal-title":"Emerg Infect Dis"},{"key":"402_CR38","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jgar.2019.01.029","volume":"18","author":"Chun-Zhen Hua","year":"2019","unstructured":"Hua CZ, Wang HJ, Zhang Z et al (2019) In vitro activity and clinical efficacy of macrolides, cefoperazone-sulbactam and piperacillin\/piperacillin-tazobactam against Bordetella pertussis and the clinical manifestations in pertussis patients due to these isolatesA single-center study in Zhejiang Province, China. J Glob Antimicrob Resist. \nhttps:\/\/doi.org\/10.1016\/j.jgar.2019.01.029","journal-title":"Journal of Global Antimicrobial Resistance"},{"issue":"4","key":"402_CR39","doi-asserted-by":"crossref","first-page":"282","DOI":"10.21101\/cejph.a4948","volume":"25","author":"V Jakubu","year":"2017","unstructured":"Jakubu V, Zavadilova J, Fabianova K et al (2017) Trends in the minimum inhibitory concentrations of erythromycin, clarithromycin, azithromycin, ciprofloxacin, and trimethoprim\/sulfamethoxazole for strains of bordetella pertussis isolated in the Czech Republic in 1967\u20132015. Cent Eur J Public Health 25(4):282\u2013286","journal-title":"Cent Eur J Public Health"},{"issue":"7","key":"402_CR40","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1586\/erv.09.46","volume":"8","author":"T Kallonen","year":"2009","unstructured":"Kallonen T, He Q (2009) Bordetella pertussis strain variation and evolution postvaccination. Expert Rev Vaccines 8(7):863\u2013875","journal-title":"Expert Rev Vaccines"},{"issue":"2","key":"402_CR41","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.cmi.2018.10.005","volume":"25","author":"T Kastrin","year":"2019","unstructured":"Kastrin T, Barkoff AM, Paragi M et al (2019) High prevalence of currently circulating Bordetella pertussis isolates not producing vaccine antigen pertactin in Slovenia. Clin Microbiol Infect 25(2):258\u2013260","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"402_CR42","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1128\/CMR.00083-15","volume":"29","author":"PE Kilgore","year":"2016","unstructured":"Kilgore PE, Salim AM, Zervos MJ et al (2016) Pertussis: microbiology, disease, treatment, and prevention. Clin Microbiol Rev 29(3):449\u2013486","journal-title":"Clin Microbiol Rev"},{"key":"402_CR43","unstructured":"Lam C, Octavia S, Ricafort L et al (2013) Emergence of pertactin deficient Bordetella pertussis in Australia is due to independent events. In: 10th international symposium on bordetella, Dublin, Ireland, Poster(P11)"},{"issue":"4","key":"402_CR44","first-page":"626","volume":"20","author":"C Lam","year":"2014","unstructured":"Lam C, Octavia S, Ricafort L et al (2014) Rapid Increase in Pertactin-deficient Bordetella pertussis Isolates, Australia. Emerg Infect Dis 20(4):626\u2013633","journal-title":"Emerg Infect Dis"},{"issue":"3","key":"402_CR45","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1128\/JCM.01838-08","volume":"47","author":"DJ Litt","year":"2009","unstructured":"Litt DJ, Neal SE, Fry NK (2009) Changes in genetic diversity of the Bordetella pertussis population in the United Kingdom between 1920 and 2006 reflect vaccination coverage and emergence of a single dominant clonal type. J Clin Microbiol 47(3):680\u2013688","journal-title":"J Clin Microbiol"},{"key":"402_CR46","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jgar.2018.02.012","volume":"14","author":"E Lonnqvist","year":"2018","unstructured":"Lonnqvist E, Barkoff AM, Mertsola J et al (2018) Antimicrobial susceptibility testing of Finnish Bordetella pertussis isolates collected during 2006\u20132017. J Glob Antimicrob Resist 14:12\u201316","journal-title":"J Glob Antimicrob Resist"},{"issue":"9","key":"402_CR47","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.4161\/hv.25407","volume":"9","author":"K Mahmood","year":"2013","unstructured":"Mahmood K, Pelkowski S, Atherly D et al (2013) Hexavalent IPV-based combination vaccines for public-sector markets of low-resource countries. Hum Vaccin Immunother 9(9):1894\u20131902","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"402_CR48","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1093\/cid\/ciu788","volume":"60","author":"SW Martin","year":"2015","unstructured":"Martin SW, Pawloski L, Williams M et al (2015) Pertactin-negative Bordetella pertussis strains: evidence for a possible selective advantage. Clin Infect Dis 60(2):223\u2013227","journal-title":"Clin Infect Dis"},{"issue":"Pt 8","key":"402_CR49","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1099\/13500872-145-8-2069","volume":"145","author":"P Mastrantonio","year":"1999","unstructured":"Mastrantonio P, Spigaglia P, van Oirschot H et al (1999) Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children. Microbiology 145(Pt 8):2069\u20132075","journal-title":"Microbiology"},{"issue":"2","key":"402_CR50","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1128\/CMR.18.2.326-382.2005","volume":"18","author":"S Mattoo","year":"2005","unstructured":"Mattoo S, Cherry JD (2005) Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev 18(2):326\u2013382","journal-title":"Clin Microbiol Rev"},{"issue":"10","key":"402_CR51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0077165","volume":"8","author":"Y Miyaji","year":"2013","unstructured":"Miyaji Y, Otsuka N, Toyoizumi-Ajisaka H et al (2013) Genetic Analysis of Bordetella pertussis Isolates from the 2008\u20132010 pertussis epidemic in Japan. PLoS One 8(10):e77165","journal-title":"PLoS One"},{"issue":"2","key":"402_CR52","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1128\/IAI.66.2.670-675.1998","volume":"66","author":"FR Mooi","year":"1998","unstructured":"Mooi FR, van Oirschot H, Heuvelman K et al (1998) Polymorphism in the Bordetella pertussis virulence factors P.69\/pertactin and pertussis toxin in The Netherlands: temporal trends and evidence for vaccine-driven evolution. Infect Immun 66(2):670\u2013675","journal-title":"Infect Immun"},{"issue":"6","key":"402_CR53","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1128\/IAI.67.6.3133-3134.1999","volume":"67","author":"FR Mooi","year":"1999","unstructured":"Mooi FR, He Q, van Oirschot H et al (1999) Variation in the Bordetella pertussis virulence factors pertussis toxin and pertactin in vaccine strains and clinical isolates in Finland. Infect Immun 67(6):3133\u20133134","journal-title":"Infect Immun"},{"issue":"3","key":"402_CR54","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1007\/s100960050455","volume":"19","author":"FR Mooi","year":"2000","unstructured":"Mooi FR, Hallander H, Wirsing von Konig CH et al (2000) Epidemiological typing of Bordetella pertussis isolates: recommendations for a standard methodology. Eur J Clin Microbiol Infect Dis 19(3):174\u2013181","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"402_CR55","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.3201\/eid1508.081511","volume":"15","author":"FR Mooi","year":"2009","unstructured":"Mooi FR, van Loo IH, van Gent M et al (2009) Bordetella pertussis strains with increased toxin production associated with pertussis resurgence. Emerg Infect Dis 15(8):1206\u20131213","journal-title":"Emerg Infect Dis"},{"key":"402_CR56","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1017\/S0950268813000071","volume":"142","author":"FR Mooi","year":"2013","unstructured":"Mooi FR, van der Maas NA, De Melker HE (2013) Pertussis resurgence: waning immunity and pathogen adaptation \u2013 two sides of the same coin. Epidemiol Infect 142:685\u2013694. \nhttps:\/\/doi.org\/10.1017\/S0950268813000071","journal-title":"Epidemiol Infect"},{"key":"402_CR57","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijid.2017.07.015","volume":"62","author":"T Moriuchi","year":"2017","unstructured":"Moriuchi T, Vichit O, Vutthikol Y et al (2017) Molecular epidemiology of Bordetella pertussis in Cambodia determined by direct genotyping of clinical specimens. Int J Infect Dis 62:56\u201358","journal-title":"Int J Infect Dis"},{"issue":"10","key":"402_CR58","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s10096-011-1217-y","volume":"30","author":"S Nar Otgun","year":"2011","unstructured":"Nar Otgun S, Durmaz R, Karagoz A, Ertek M et al (2011) Pulsed-field gel electrophoresis characterization of Bordetella pertussis clinical isolates circulating in Turkey in 2001\u20132009. Eur J Clin Microbiol Infect Dis 30(10):1229\u20131236","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"402_CR59","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1093\/infdis\/jis178","volume":"205","author":"S Octavia","year":"2012","unstructured":"Octavia S, Sintchenko V, Gilbert GL et al (2012) Newly emerging clones of Bordetella pertussis carrying prn2 and ptxP3 alleles implicated in Australian pertussis epidemic in 2008\u20132010. J Infect Dis 205(8):1220\u20131224","journal-title":"J Infect Dis"},{"issue":"7","key":"402_CR60","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1128\/AAC.00023-09","volume":"53","author":"M Ohtsuka","year":"2009","unstructured":"Ohtsuka M, Kikuchi K, Shimizu K et al (2009) Emergence of quinolone-resistant Bordetella pertussis in Japan. Antimicrob Agents Chemother 53(7):3147\u20133149","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"402_CR61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0031985","volume":"7","author":"N Otsuka","year":"2012","unstructured":"Otsuka N, Han HJ, Toyoizumi-Ajisaka H et al (2012) Prevalence and genetic characterization of pertactin-deficient Bordetella pertussis in Japan. PLoS One 7(2):e31985","journal-title":"PLoS One"},{"issue":"1","key":"402_CR62","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/ng1227","volume":"35","author":"J Parkhill","year":"2003","unstructured":"Parkhill J, Sebaihia M, Preston A et al (2003) Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet 35(1):32\u201340","journal-title":"Nat Genet"},{"issue":"2","key":"402_CR63","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1128\/CVI.00717-13","volume":"21","author":"LC Pawloski","year":"2014","unstructured":"Pawloski LC, Queenan AM, Cassiday PK et al (2014) Prevalence and molecular characterization of pertactin-deficient bordetella pertussis in the United States. Clin Vaccine Immunol 21(2):119\u2013125","journal-title":"Clin Vaccine Immunol"},{"issue":"3","key":"402_CR64","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1099\/jmm.0.000688","volume":"67","author":"E Petridou","year":"2018","unstructured":"Petridou E, Jensen CB, Arvanitidis A et al (2018) Molecular epidemiology of Bordetella pertussis in Greece, 2010\u20132015. J Med Microbiol 67(3):400\u2013407","journal-title":"J Med Microbiol"},{"issue":"3-4","key":"402_CR65","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.micinf.2018.12.001","volume":"21","author":"Maciej Polak","year":"2019","unstructured":"Polak M, Zasada AA, Mosiej E et al (2018) Pertactin-deficient Bordetella pertussis isolates in Poland-a country with whole-cell pertussis primary vaccination. Microbes Infect. \nhttps:\/\/doi.org\/10.1016\/j.micinf.2018.12.001","journal-title":"Microbes and Infection"},{"issue":"6","key":"402_CR66","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1056\/NEJMc1209369","volume":"368","author":"AM Queenan","year":"2013","unstructured":"Queenan AM, Cassiday PK, Evangelista A (2013) Pertactin-negative variants of Bordetella pertussis in the United States. N Engl J Med 368(6):583\u2013584","journal-title":"N Engl J Med"},{"issue":"10","key":"402_CR67","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1007\/s10096-018-3323-6","volume":"37","author":"F Sadeghpour Heravi","year":"2018","unstructured":"Sadeghpour Heravi F, Nikbin VS, Nakhost Lotfi M et al (2018) Strain variation and antigenic divergence among Bordetella pertussis circulating strains isolated from patients in Iran. Eur J Clin Microbiol Infect Dis 37(10):1893\u20131900","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"8","key":"402_CR68","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.3201\/eid1808.120082","volume":"18","author":"AJ Schmidtke","year":"2012","unstructured":"Schmidtke AJ, Boney KO, Martin SW et al (2012) Population diversity among Bordetella pertussis isolates, United States, 1935\u20132009. Emerg Infect Dis 18(8):1248\u20131255","journal-title":"Emerg Infect Dis"},{"issue":"16","key":"402_CR69","doi-asserted-by":"crossref","first-page":"5496","DOI":"10.1128\/JB.186.16.5496-5505.2004","volume":"186","author":"LM Schouls","year":"2004","unstructured":"Schouls LM, van der Heide HG, Vauterin L et al (2004) Multiple-locus variable-number tandem repeat analysis of Dutch Bordetella pertussis strains reveals rapid genetic changes with clonal expansion during the late 1990s. J Bacteriol 186(16):5496\u20135505","journal-title":"J Bacteriol"},{"issue":"2","key":"402_CR70","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1093\/infdis\/jiu665","volume":"212","author":"KL Sealey","year":"2014","unstructured":"Sealey KL, Harris SR, Fry NK et al (2014) Genomic analysis of isolates from the UK 2012 pertussis outbreak reveals that vaccine antigen genes are unusually fast evolving. J Infect Dis 212(2):294\u2013301","journal-title":"J Infect Dis"},{"issue":"6","key":"402_CR71","doi-asserted-by":"crossref","DOI":"10.5812\/jjm.10880","volume":"7","author":"F Shahcheraghi","year":"2014","unstructured":"Shahcheraghi F, Nakhost Lotfi M, Nikbin VS et al (2014) The first macrolide-resistant bordetella pertussis strains isolated from Iranian patients. Jundishapur J Microbiol 7(6):e10880","journal-title":"Jundishapur J Microbiol"},{"issue":"6","key":"402_CR72","doi-asserted-by":"crossref","first-page":"e413","DOI":"10.1016\/j.ijid.2012.12.015","volume":"17","author":"M Shuel","year":"2013","unstructured":"Shuel M, Jamieson FB, Tang P et al (2013) Genetic analysis of Bordetella pertussis in Ontario, Canada reveals one predominant clone. Int J Infect Dis 17(6):e413\u2013e417","journal-title":"Int J Infect Dis"},{"key":"402_CR73","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ijid.2014.10.028","volume":"29","author":"K Simmonds","year":"2014","unstructured":"Simmonds K, Fathima S, Chui L et al (2014) Dominance of two genotypes of Bordetella pertussis during a period of increased pertussis activity in Alberta, Canada: January to August 2012. Int J Infect Dis 29:223\u2013225","journal-title":"Int J Infect Dis"},{"issue":"2","key":"402_CR74","first-page":"159","volume":"32","author":"P Stefanelli","year":"2009","unstructured":"Stefanelli P, Fazio C, Fedele G et al (2009) A natural pertactin deficient strain of Bordetella pertussis shows improved entry in human monocyte-derived dendritic cells. New Microbiol 32(2):159\u2013166","journal-title":"New Microbiol"},{"issue":"5","key":"402_CR75","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1080\/21645515.2016.1276139","volume":"13","author":"P Stefanelli","year":"2017","unstructured":"Stefanelli P, Buttinelli G, Vacca P et al (2017) Severe pertussis infection in infants less than 6 months of age: clinical manifestations and molecular characterization. Hum Vaccin Immunother 13(5):1073\u20131077","journal-title":"Hum Vaccin Immunother"},{"key":"402_CR76","unstructured":"Torres R, Moraes P, Oliveira K (2015, October 18\u201322) Bordetella pertussis antibiotic resistance in Southern Brazil: a 3-year surveillance study. XXVIII Brazilian congress of microbiology. Accessed 1 June 2018"},{"key":"402_CR77","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijid.2014.08.002","volume":"28","author":"RS Tsang","year":"2014","unstructured":"Tsang RS, Shuel M, Jamieson FB et al (2014) Pertactin-negative Bordetella pertussis strains in Canada: characterization of a dozen isolates based on a survey of 224 samples collected in different parts of the country over the last 20 years. Int J Infect Dis 28:65\u201369","journal-title":"Int J Infect Dis"},{"issue":"6","key":"402_CR78","doi-asserted-by":"crossref","first-page":"2837","DOI":"10.1128\/JCM.43.6.2837-2843.2005","volume":"43","author":"SC Amersfoorth van","year":"2005","unstructured":"van Amersfoorth SC, Schouls LM, van der Heide HG et al (2005) Analysis of Bordetella pertussis populations in European countries with different vaccination policies. J Clin Microbiol 43(6):2837\u20132843","journal-title":"J Clin Microbiol"},{"issue":"41","key":"402_CR79","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1016\/j.vaccine.2013.07.060","volume":"31","author":"NA Maas van der","year":"2013","unstructured":"van der Maas NA, Mooi FR, de Greeff SC et al (2013) Pertussis in the Netherlands, is the current vaccination strategy sufficient to reduce disease burden in young infants? Vaccine 31(41):4541\u20134547","journal-title":"Vaccine"},{"issue":"4","key":"402_CR80","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s10096-014-2297-2","volume":"34","author":"M Gent van","year":"2015","unstructured":"van Gent M, Heuvelman CJ, van der Heide HG et al (2015) Analysis of Bordetella pertussis clinical isolates circulating in European countries during the period 1998\u20132012. Eur J Clin Microbiol Infect Dis 34(4):821\u2013830","journal-title":"Eur J Clin Microbiol Infect Dis"},{"issue":"6","key":"402_CR81","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1128\/JCM.40.6.1994-2001.2002","volume":"40","author":"IH Loo van","year":"2002","unstructured":"van Loo IH, Heuvelman KJ, King AJ et al (2002) Multilocus sequence typing of Bordetella pertussis based on surface protein genes. J Clin Microbiol 40(6):1994\u20132001","journal-title":"J Clin Microbiol"},{"issue":"7","key":"402_CR82","volume":"10","author":"B Wagner","year":"2015","unstructured":"Wagner B, Melzer H, Freymuller G et al (2015) Genetic Variation of Bordetella pertussis in Austria. PLoS One 10(7):e0132623","journal-title":"PLoS One"},{"issue":"6","key":"402_CR83","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1093\/cid\/civ457","volume":"61","author":"Z Wang","year":"2015","unstructured":"Wang Z, He Q (2015) Bordetella pertussis Isolates circulating in China where whole cell Vaccines have been used for 50 years. Clin Infect Dis 61(6):1028\u20131029","journal-title":"Clin Infect Dis"},{"issue":"11","key":"402_CR84","doi-asserted-by":"crossref","first-page":"O825","DOI":"10.1111\/1469-0691.12671","volume":"20","author":"Z Wang","year":"2014","unstructured":"Wang Z, Cui Z, Li Y et al (2014) High prevalence of erythromycin-resistant Bordetella pertussis in Xi\u2019an, China. Clin Microbiol Infect 20(11):O825\u2013O830","journal-title":"Clin Microbiol Infect"},{"issue":"11","key":"402_CR85","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.1128\/JCM.01499-15","volume":"53","author":"Z Wang","year":"2015","unstructured":"Wang Z, Han R, Liu Y et al (2015) Direct detection of erythromycin-resistant Bordetella pertussis in clinical specimens by PCR. J Clin Microbiol 53(11):3418\u20133422","journal-title":"J Clin Microbiol"},{"issue":"2","key":"402_CR86","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1586\/14760584.4.2.173","volume":"4","author":"M Watanabe","year":"2005","unstructured":"Watanabe M, Nagai M (2005) Acellular pertussis vaccines in Japan: past, present and future. Expert Rev Vaccines 4(2):173\u2013184","journal-title":"Expert Rev Vaccines"},{"key":"402_CR87","doi-asserted-by":"publisher","unstructured":"Weigand MR, Peng Y, Cassiday PK et al (2017a) Complete genome sequences of bordetella pertussis isolates with novel pertactin-deficient deletions. Genome Announc 5(37). \nhttps:\/\/doi.org\/10.1128\/genomeA.00973-17","DOI":"10.1128\/genomeA.00973-17"},{"issue":"8","key":"402_CR88","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/JB.00806-16","volume":"199","author":"MR Weigand","year":"2017","unstructured":"Weigand MR, Peng Y, Loparev V et al (2017b) The history of bordetella pertussis genome evolution includes structural rearrangement. J Bacteriol 199(8):10","journal-title":"J Bacteriol"},{"issue":"4","key":"402_CR89","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1128\/IAI.00869-17","volume":"86","author":"MR Weigand","year":"2018","unstructured":"Weigand MR, Pawloski LC, Peng Y et al (2018) Screening and genomic characterization of filamentous hemagglutinin-deficient bordetella pertussis. Infect Immun 86(4):10","journal-title":"Infect Immun"},{"issue":"9","key":"402_CR90","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1002\/j.1460-2075.1990.tb07468.x","volume":"9","author":"R Willems","year":"1990","unstructured":"Willems R, Paul A, van der Heide HG et al (1990) Fimbrial phase variation in Bordetella pertussis: a novel mechanism for transcriptional regulation. EMBO J 9(9):2803\u20132809","journal-title":"EMBO J"},{"issue":"2","key":"402_CR91","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3201\/eid2202.151332","volume":"22","author":"MM Williams","year":"2016","unstructured":"Williams MM, Sen K, Weigand MR et al (2016) Bordetella pertussis strain lacking pertactin and pertussis toxin. Emerg Infect Dis 22(2):319\u2013322","journal-title":"Emerg Infect Dis"},{"issue":"8","key":"402_CR92","doi-asserted-by":"crossref","first-page":"2942","DOI":"10.1128\/JCM.40.8.2942-2944.2002","volume":"40","author":"KE Wilson","year":"2002","unstructured":"Wilson KE, Cassiday PK, Popovic T et al (2002) Bordetella pertussis isolates with a heterogeneous phenotype for erythromycin resistance. J Clin Microbiol 40(8):2942\u20132944","journal-title":"J Clin Microbiol"},{"issue":"6","key":"402_CR93","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/j.jpeds.2012.05.041","volume":"161","author":"K Winter","year":"2012","unstructured":"Winter K, Harriman K, Zipprich J et al (2012) California pertussis epidemic, 2010. J Pediatr 161(6):1091\u20131096","journal-title":"J Pediatr"},{"issue":"48","key":"402_CR94","first-page":"1129","volume":"63","author":"K Winter","year":"2014","unstructured":"Winter K, Glaser C, Watt J et al (2014) Pertussis epidemic--California, 2014. MMWR Morb Mortal Wkly Rep 63(48):1129\u20131132","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"402_CR95","doi-asserted-by":"crossref","first-page":"12888","DOI":"10.1038\/srep12888","volume":"5","author":"Y Xu","year":"2015","unstructured":"Xu Y, Liu B, Grondahl-Yli-Hannuksila K et al (2015a) Whole-genome sequencing reveals the effect of vaccination on the evolution of Bordetella pertussis. Sci Rep 5:12888","journal-title":"Sci Rep"},{"issue":"46","key":"402_CR96","doi-asserted-by":"crossref","first-page":"6327","DOI":"10.1016\/j.vaccine.2015.09.040","volume":"33","author":"Y Xu","year":"2015","unstructured":"Xu Y, Zhang L, Tan Y et al (2015b) Genetic diversity and population dynamics of Bordetella pertussis in China between 1950\u20132007. Vaccine 33(46):6327\u20136331","journal-title":"Vaccine"},{"issue":"9","key":"402_CR97","volume":"10","author":"Y Yang","year":"2015","unstructured":"Yang Y, Yao K, Ma X et al (2015) Variation in bordetella pertussis susceptibility to erythromycin and virulence-related genotype changes in China (1970\u20132014). PLoS One 10(9):e0138941","journal-title":"PLoS One"},{"issue":"33","key":"402_CR98","doi-asserted-by":"crossref","first-page":"20881","DOI":"10.2807\/1560-7917.ES2014.19.33.20881","volume":"19","author":"A Zeddeman","year":"2014","unstructured":"Zeddeman A, van Gent M, Heuvelman CJ et al (2014) Investigations into the emergence of pertactin-deficient Bordetella pertussis isolates in six European countries, 1996 to 2012. Euro Surveill 19(33):20881","journal-title":"Euro Surveill"},{"issue":"11","key":"402_CR99","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.3201\/eid1611.100401","volume":"16","author":"L Zhang","year":"2010","unstructured":"Zhang L, Xu Y, Zhao J et al (2010) Effect of vaccination on Bordetella pertussis strains, China. Emerg Infect Dis 16(11):1695\u20131701","journal-title":"Emerg Infect Dis"},{"key":"402_CR100","doi-asserted-by":"publisher","unstructured":"Zomer A, Otsuka N, Hiramatsu Y et al (2018) Bordetella pertussis population dynamics and phylogeny in Japan after adoption of acellular pertussis vaccines. Microb Genom 4. \nhttps:\/\/doi.org\/10.1099\/mgen.0.000180","DOI":"10.1099\/mgen.0.000180"}],"container-title":["Advances in Experimental Medicine and Biology","Pertussis Infection and Vaccines"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/5584_2019_402","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,6]],"date-time":"2020-01-06T13:07:30Z","timestamp":1578316050000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/5584_2019_402"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"ISBN":["9783030332488","9783030332495"],"references-count":100,"URL":"https:\/\/doi.org\/10.1007\/5584_2019_402","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"25 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}